We've closed a $48.5M #SeriesA financing round. This funding supports our #PremarketApproval submission for the #ReviventTC, expanding access to allow additional procedures. We've also appointed Raphael Wisniewski & Bihua Chen to our Board of Directors: prn.to/4005YTC
BioVentrix
@BioVentrix
#MedicalDevice company working to improve and expand the treatment available for congestive #heartfailure.
1.1K Following 724 Followers 461 Posts
Latest posts 5
#THT2023 is over! Thank you to the @CRFHeart for a great event. We also want to thank all those who joined us for our lunch symposium. If you didn't get a chance to meet with us at THT, set up a meeting at bioventrix.com. #heartfailure #interventionalcardiology
Hello Boston! We are excited about our lunch symposium today and can't wait to meet and discuss the next frontier in interventional heart failure. Take a look at our program at https://t.co/180V4QIe2f.
We hope to see you there!
#THT2023 #HeartFailure #InterventionalCardiology
We hope to see you there!
#THT2023 #HeartFailure #InterventionalCardiology
#THT2023 is just days away. Join us at the BioVentrix Lunch Symposium where we'll discuss The Left Ventricle: Interventional Heart Failure's Next Frontier.
Contact us today to learn more: https://t.co/UVN22TtHTi. #HeartFailure #InterventionalCardiology
Contact us today to learn more: https://t.co/UVN22TtHTi. #HeartFailure #InterventionalCardiology
We are excited to announce distinguished #cardiologist Ori Ben-Yehuda, MD, as our new Chief Medical Officer. With years of experience in the field, he will play a critical role to our team as we move into the advanced stages of #PremarketApproval: prn.to/3RLzqtX